EUVIMEDEUVIMED entdecken
Crossref

Ursolic acid ameliorates doxorubicin-induced cardiotoxicity by inhibiting DRP1-mediated excessive mitochondrial fission and oxidative stress

Dejian Lin, Xinqing Dai, Mingyue Tang, Ya Wu, Haixia Xu

European Journal of Pharmacology · 2026

DOI: 10.1016/j.ejphar.2025.178482 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pharmacology, 2026. Verfasst von Dejian Lin und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China. Hauptthemen laut MEDLINE: Triterpenes, Oxidative Stress, Mitochondrial Dynamics, Doxorubicin. Die Arbeit nennt 41 Literaturangaben. Gefördert von: Nantong University, National Natural Science Foundation of China, Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Doxorubicin (DOX) is a commonly used chemotherapeutic agent for treating hematologic malignancies and breast cancer. However, its clinical application is limited by severe cardiotoxicity. Recent studies have suggested that mitochondrial dynamics play a central role in the pathogenesis of doxorubicin-induced cardiotoxicity (DIC). This study was designed to evaluate whether ursolic acid (UA) can mitigate DIC and elucidate the underlying mechanisms related to mitochondrial fission and oxidative stress. METHODS: A chronic DOX-induced cardiotoxicity model was established via the intraperitoneal administration of DOX (5 mg/kg/week), while ursolic acid was administered intragastrically (50 mg/kg/day). Echocardiography and histological staining were employed to assess the protective effects of ursolic acid on DOX-induced cardiac injury. RESULTS: Ursolic acid treatment significantly improved cardiac function following DOX exposure. Immunofluorescence analysis confirmed the amelioration of mitochondrial dysfunction. Western blotting demonstrated that ursolic acid markedly reduced the DOX-induced increase in the level of dynamin-related protein 1 (DRP1) phosphorylated at Ser616 (p-DRP1(S616)), suggesting its role in attenuating excessive mitochondrial fission. Furthermore, co-treatment with Mitochondrial Division Inhibitor 1 (Mdivi-1) further suppressed p-DRP1 (S616) expression, reinforcing the notion that ursolic acid mitigates DIC by inhibiting DRP1-mediated mitochondrial fission and oxidative stress. The upstream mechanism was explored, with evidence suggesting that the C5a-C5a1 receptor axis mediates p-DRP1(S616) phosphorylation. Western blot analysis revealed significant upregulation of the C5a and C5a1 receptors in the DIC model. The C5a1 receptor agonist BM213 abolished the protective effects of ursolic acid, indicating that ursolic acid exerts its cardioprotective effect by inhibiting the C5a-C5aR1-DRP1(S616) pathway. CONCLUSION: Ursolic acid confers protection against DOX-induced cardiotoxicity by improving mitochondrial function through the inhibition of DRP1-mediated excessive mitochondrial fission and oxidative stress.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TriterpenesOxidative StressMitochondrial DynamicsDoxorubicinDynaminsCardiotoxicityUrsolic AcidAnimalsMaleMiceMyocytes, Cardiac

Stichwörter der Autor:innen

Doxorubicin-induced cardiotoxicityMitochondrial fissionOxidative stressUrsolic acidp-DRP1(S616)

Substanzen

Ursolic AcidTriterpenesDoxorubicinDynaminsDnm1l protein, mouse

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China.
  • Department of Cardiology, Affiliated Hospital of Nantong University, Jiangsu, 226001, China. Electronic address: ntxhx2005@ntu.edu.cn.

Förderung

  • Nantong University
  • National Natural Science Foundation of China
  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Lin, D., Dai, X., Tang, M., Wu, Y., & Xu, H. (2026). Ursolic acid ameliorates doxorubicin-induced cardiotoxicity by inhibiting DRP1-mediated excessive mitochondrial fission and oxidative stress. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2025.178482

Vancouver

Lin D, Dai X, Tang M, Wu Y, Xu H. Ursolic acid ameliorates doxorubicin-induced cardiotoxicity by inhibiting DRP1-mediated excessive mitochondrial fission and oxidative stress. European Journal of Pharmacology. 2026. doi:10.1016/j.ejphar.2025.178482

BibTeX
@article{Lin2026,
  author = {Lin, Dejian and Dai, Xinqing and Tang, Mingyue and Wu, Ya and Xu, Haixia},
  title = {Ursolic acid ameliorates doxorubicin-induced cardiotoxicity by inhibiting DRP1-mediated excessive mitochondrial fission and oxidative stress},
  journal = {European Journal of Pharmacology},
  year = {2026},
  doi = {10.1016/j.ejphar.2025.178482}
}
Kostenlos starten →